O
33
2
UHS
55
3
LRCX
62
6
GOOG
57
2
STI
18
11
BAX
38
-12
NOC
54
6
L
71
2
PLD
30
2
PM
49
2
SWKS
55
2
FE
48
-4
AIG
77
2
C
82
3
XYL
33
6
HRB
46
4
MCK
67
3
TDC
70
3
ABBV
59
13
EBAY
53
3
O
33
2
UHS
55
3
LRCX
62
6
GOOG
57
2
STI
18
11
BAX
38
-12
NOC
54
6
L
71
2
PLD
30
2
PM
49
2
SWKS
55
2
FE
48
-4
AIG
77
2
C
82
3
XYL
33
6
HRB
46
4
MCK
67
3
TDC
70
3
ABBV
59
13
EBAY
53
3
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Hims & Hers Health, Inc. Industry Stock Comparison

Buy
64

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.01
Seasonality Move:
0.94%
Sell
36

HIMS
Hims & Hers Health, Inc.

Last Price:
$35.60
Seasonality Move:
21.52%
Buy
64
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.01. The Score for JQC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Hims & Hers Health, Inc. (HIMS) is a Sell

Is Hims & Hers Health, Inc. a Buy, Sell or Hold?

  • The current Hims & Hers Health, Inc. [HIMS] share price is $35.56. The Score for HIMS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • HIMS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.01
    The current trend is relatively stagnant and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.

HIMS Stock Price Chart

What is Hims & Hers Health, Inc.'s stock price today?

  • The Hims & Hers Health, Inc. share price today is $35.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIMS is experiencing buying pressure, which is a positive indicator for future bullish movement.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.25 Sell
Chaikin Money Flow: 823768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.99 - 5.07) Sell
Bollinger Bands (100): (5.05 - 5.45) Sell

HIMS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.55 Sell
Relative Strength Index (14 RSI): 40.57 Sell
Chaikin Money Flow: 7210044 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.36 - 38.74) Sell
Bollinger Bands (100): (38.82 - 54.82) Sell

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.02 Sell
20-day SMA: 5.05 Sell
50-day SMA: 5.07 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.02 Sell
20-day EMA: 5.04 Sell
50-day EMA: 5.1 Sell
200-day EMA: 5.29 Sell

HIMS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.41 Sell
20-day SMA: 37.4 Sell
50-day SMA: 42.14 Sell
200-day SMA: 45.77 Sell
8-day EMA: 36.26 Sell
20-day EMA: 37.52 Sell
50-day EMA: 41.17 Sell
200-day EMA: 43.23 Sell

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Hims & Hers Health, Inc. Earnings Growth & HIMS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.16 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Hims & Hers Health, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):